002688.SZ · 金河生物
China A-shares · RS rating 49 · As of 2026-10-14
| Price | 5.06 CNY |
|---|---|
| 1-day change | -2.1% |
| RS rating (overall / 1M / 3M / 12M) | 49 / 52 / 59 / 33 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 21 / 9 / 14 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -4.9% |
| Distance from 52-week high | +28.8% |
| Market cap (USD) | $663.7M |